Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 643,062
  • Shares Outstanding, K 301,907
  • Annual Sales, $ 154,010 K
  • Annual Income, $ -309,850 K
  • EBIT $ -191 M
  • EBITDA $ 34 M
  • 60-Month Beta 2.20
  • Price/Sales 4.73
  • Price/Cash Flow N/A
  • Price/Book 16.73

Options Overview Details

View History
  • Implied Volatility 117.28% (+6.07%)
  • Historical Volatility 74.23%
  • IV Percentile 53%
  • IV Rank 10.32%
  • IV High 412.87% on 04/16/25
  • IV Low 83.27% on 08/25/25
  • Expected Move (DTE 2) 0.31 (12.97%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,769
  • Volume Avg (30-Day) 2,355
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 119,177
  • Open Int (30-Day) 122,555
  • Expected Range 2.05 to 2.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.67 +41.32%
on 12/29/25
2.37 -0.42%
on 01/14/26
+0.24 (+11.32%)
since 12/12/25
3-Month
1.52 +54.91%
on 11/18/25
2.72 -13.39%
on 11/25/25
+0.77 (+48.43%)
since 10/14/25
52-Week
0.85 +177.65%
on 05/28/25
2.72 -13.39%
on 11/25/25
+0.51 (+27.57%)
since 01/14/25

Most Recent Stories

More News
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration...

PACB : 2.36 (+10.80%)
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s...

PACB : 2.36 (+10.80%)
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the...

PACB : 2.36 (+10.80%)
3 Reasons to Sell PACB and 1 Stock to Buy Instead

3 Reasons to Sell PACB and 1 Stock to Buy Instead

PACB : 2.36 (+10.80%)
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that...

PACB : 2.36 (+10.80%)
3 Unprofitable Stocks That Concern Us

3 Unprofitable Stocks That Concern Us

ENOV : 24.27 (-1.58%)
PACB : 2.36 (+10.80%)
BGS : 4.26 (+1.91%)
PacBio (PACB) Stock Is Up, What You Need To Know

PacBio (PACB) Stock Is Up, What You Need To Know

PACB : 2.36 (+10.80%)
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24

Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24

ONTF : 7.97 (+0.13%)
FCEL : 7.49 (-0.40%)
PACB : 2.36 (+10.80%)
CROX : 83.54 (-2.14%)
AMC : 1.5500 (-3.73%)
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

CORT : 37.04 (+1.90%)
FCEL : 7.49 (-0.40%)
PACB : 2.36 (+10.80%)
Why Is PacBio (PACB) Stock Soaring Today

Why Is PacBio (PACB) Stock Soaring Today

PACB : 2.36 (+10.80%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 2.70
2nd Resistance Point 2.53
1st Resistance Point 2.45
Last Price 2.36
1st Support Level 2.20
2nd Support Level 2.03
3rd Support Level 1.95

See More

52-Week High 2.72
Last Price 2.36
Fibonacci 61.8% 2.01
Fibonacci 50% 1.79
Fibonacci 38.2% 1.57
52-Week Low 0.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar